ALTERATIONS IN NA+-K+-ATPASE ACTIVITY AND BETA-ENDORPHIN CONTENT IN ACUTE ISCHEMIC BRAIN WITH AND WITHOUT NALOXONE TREATMENT

被引:31
作者
FURUI, T [1 ]
TANAKA, I [1 ]
IWATA, K [1 ]
机构
[1] HAMAMATSU UNIV SCH MED, DEPT INTERNAL MED, HAMAMATSU, SHIZUOKA 43131, JAPAN
关键词
adenosine triphosphatase; ischemia; naloxone; rat; β-endorphin;
D O I
10.3171/jns.1990.72.3.0458
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The Na+-K+-adenosine triphosphatase (Na+-K+-ATPase) activity and β-endorphin immunoreactivity were determined in rat brain at the acute stage of ischemia produced by unilateral occlusion of the middle cerebral artery (MCA). The effect of pretreatment with naloxone on these activities was also evaluated in the same model. After MCA occlusion, Na-K+-ATPase activity was promptly reduced in the ischemic hemisphere and remained at a lower level then in the contralateral hemisphere during 90 minutes of ischemia. A single intra-peritoneal 0.5-mg injection of naloxone prior to MCA occlusion attenuated the inactivation. On the other hand, β-endorphin immunoreactivity was significantly increased following ischemia. The increase was marked in the ischemic hemisphere and was also observed in the contralateral hemisphere; this increase was not affected by the administration of naloxone. These results indicate the possibility that naloxone contributes to protecting the brain from ischemia through stabilizing the cellular membrane. The possible mechanism by which naloxone attenuates the inactivation of Na+-K+-ATPase in the ischemic brain is discussed in view of alterations of the central β-endorphin system during ischemia.
引用
收藏
页码:458 / 462
页数:5
相关论文
共 31 条
[1]   NALOXONE REVERSAL OF ISCHEMIC NEUROLOGIC DEFICITS IN BABOONS IS NOT MEDIATED BY SYSTEMIC EFFECTS [J].
BASKIN, DS ;
KIECK, CF ;
HOSOBUCHI, Y .
LIFE SCIENCES, 1982, 31 (20-2) :2201-2204
[2]   TREATMENT OF EXPERIMENTAL STROKE WITH OPIATE ANTAGONISTS - EFFECTS ON NEUROLOGICAL FUNCTION, INFARCT SIZE, AND SURVIVAL [J].
BASKIN, DS ;
HOSOBUCHI, Y ;
GREVEL, JC .
JOURNAL OF NEUROSURGERY, 1986, 64 (01) :99-103
[3]  
BASKIN DS, 1981, LANCET, V2, P272
[4]   PROTECTIVE ACTIONS OF NALOXONE IN HEMORRHAGIC-SHOCK [J].
CURTIS, MT ;
LEFER, AM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1980, 239 (03) :H416-H421
[5]   OPIOCORTIN PEPTIDES - LOCALIZATION, SOURCE AND AVENUES OF TRANSPORT [J].
DEKLOET, ER ;
PALKOVITS, M ;
MEZEY, E .
PHARMACOLOGY & THERAPEUTICS, 1981, 12 (02) :321-351
[6]  
DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91
[7]   TREATMENT OF EXPERIMENTAL STROKE - COMPARISON OF NALOXONE AND THYROTROPIN RELEASING HORMONE [J].
FADEN, AI ;
HALLENBECK, JM ;
BROWN, CQ .
NEUROLOGY, 1982, 32 (10) :1083-1087
[8]  
Fiske CH, 1925, J BIOL CHEM, V66, P375
[9]   INCREASE OF BETA-ENDORPHIN LEVELS IN CEREBROSPINAL-FLUID BUT NOT IN PLASMA IN PATIENTS WITH CEREBRAL INFARCTION [J].
FURUI, T ;
SATOH, K ;
ASANO, Y ;
SHIMOSAWA, S ;
HASUO, M ;
YAKSH, TL .
JOURNAL OF NEUROSURGERY, 1984, 61 (04) :748-751
[10]   EFFECT OF NALOXONE ON EXPERIMENTAL STROKE IN AWAKE MONKEYS [J].
GAINES, C ;
NEHLS, DG ;
SUESS, DM ;
WAGGENER, JD ;
CROWELL, RM .
NEUROSURGERY, 1984, 14 (03) :308-314